Antimitotic Agents: all 5,052 studies that test it
Page 30 of 51. Open to participants first (616), then studies with results posted, then the rest; newest registration first within each.
- International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study)Active, not recruitingNCT02305654Phase 3
- Study of Trametinib and Nab-paclitaxel in Patients With MelanomaWithdrawnNCT02300935Phase 1
- NOV120401 (CKD-516 Tablet) for Advanced Solid TumorsStatus unknownNCT02300467Phase 1
- Dose-dense Biweekly Docetaxel, Oxaliplatin and 5-fluorouracil as First-line Treatment in Advanced Gastric CancerStatus unknownNCT02289378Phase 2
- Evaluation for the Individualization of Therapy in Adenocarcinomas of the Gastroesophageal JunctionCompletedNCT02287129Phase 2
- Nab-Paclitaxel Plus Gemcitabine With Concurrent MR-Guided IMRT in Patients With Locally Advanced Pancreatic CancerCompletedNCT02283372Phase 1
- A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung CancerCompletedNCT02283320Phase 2
- Colchicine in Atrial Fibrillation to Prevent StrokeCompletedNCT02282098Phase 3
- Multicenter Randomized Controlled Trial Adjuvant Chemotherapy vs Observation in pStage Ib Lung AdenocarcinomaStatus unknownNCT02281708Phase 3
- Post-MI PET Scan Imaging of InflammationStatus unknownNCT02281305Phase 4
- Rollover Protocol for Subjects Who Have Responded on Study 4218s - A Phase 2 StudyCompletedNCT02279602Phase 2
- Study With Pazopanib and Weekly Paclitaxel in Penile Carcinoma (PAZOPEN-SOGUG)TerminatedNCT02279576Phase 2
- Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal CarcinomaStatus unknownNCT02279134Phase 2/3
- Brentuximab Vedotin Followed by ABVD in Patients With Previously Untreated Hodgkin LymphomaStatus unknownNCT02275598Phase 2
- Pharmacokinetic Study of Docetaxel-PNP and Taxotere to Treat Patient With Advanced Solid CancerCompletedNCT02274610Phase 1
- Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line TreatmentWithdrawnNCT02274012Phase 2
- The Addition of Nab-paclitaxel (Abraxane) to First Line Treatment of Metastasized Oesophagogastric Carcinoma (ACTION)CompletedNCT02273713Phase 1/2
- A Study of Chemoradiotherapy Using Gem Plus Nab-paclitaxel for Pancreatic CancerCompletedNCT02272738Phase 1
- Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell CarcinomaActive, not recruitingNCT02270814Phase 2
- Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial CancersCompletedNCT02269293Phase 1
- Platinum-Cetuximab Combined With Docetaxel or With 5FU in Patients With Recurrent/Metastatic HNSCCCompletedNCT02268695Phase 2
- Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic HyperbilirubinemiaTerminatedNCT02267707Phase 1
- Eribulin Plus Gemcitabine (EG) vs Paclitaxel Plus Gemcitabine (PG) in HER2-Negative Metastatic Breast CancerCompletedNCT02263495Phase 2
- The Efficacy and Safety of Nab-paclitaxel in Pretreated Patients With Extensive Disease of Small Cell Lung CancerStatus unknownNCT02262897Phase 2
- Impact of Colchicine Therapy on Arrhythmia Recurrence After Acute Pericardial EffusionCompletedNCT02260206Phase 4
- Study of Itacitinib in Combination With Docetaxel in Subjects With Non-Small Cell Lung CancerTerminatedNCT02257619Phase 2
- Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate CancerStatus unknownNCT02254785Phase 2
- Clinical Study of UTD1 Injection in Combination With Capecitabine in Patients With Advanced and Metastatic Breast CancerCompletedNCT02253459Phase 3
- A Study of Safety and Pharmacokinetics of Volitinib With Docetaxel in Patients With Advanced Gastric CancerCompletedNCT02252913Phase 1
- Phase I Hypofractionated Stereotactic Boost (Radiotherapy) for Non-Small Cell Lung CancerTerminatedNCT02252796Phase 1
- Nab-Paclitaxel as Salvage Treatment in Locally Advanced or Metastatic Gastric CancerCompletedNCT02251951Phase 2
- Safety, Feasibility and Effect of TTFields (200 kHz) Concomitant With Weekly Paclitaxel in Recurrent Ovarian Carcinoma (INNOVATE)Status unknownNCT02244502Phase 1/2
- Study of Gemcitabine and Abraxane for Pancreas CancerTerminatedNCT02242409Phase 2
- Study of Afuresertib Combined With Paclitaxel in Gastric CancerCompletedNCT02240212Phase 1
- Prevention of Paclitaxel Neuropathy With CryotherapyStatus unknownNCT02230319Phase 2
- Albumin Bound Paclitaxel Plus S-1 as the First Line Chemotherapy in Advanced or Recurrent Gastric CancerCompletedNCT02229058Phase 2
- Phase II Study of Albumin Bound Paclitaxel With 5-FU and CF as Second Line in Taxanes Naive Advanced Gastric CancerStatus unknownNCT02229045Phase 2
- Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracyclines and TaxanesCompletedNCT02225470Phase 3
- Cisplatin, Docetaxel, and Nintedanib Before Surgery in Treating Patients With Previously Untreated Stage IB-IIIA Non-small Cell Lung CancerCompletedNCT02225405Phase 1
- A Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Failed First-Line Dacabazine or Temozolomide Contained TherapyCompletedNCT02223884Phase 2
- Evaluation of the Tolerance of Afatinib in Combination With Docetaxel and Cisplatin in LAHNSCC Induction ChemotherapyCompletedNCT02216617Phase 1
- Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Eribulin Chemotherapy (ACE) in Operable HER2-negative Breast CancerWithdrawnNCT02215876Phase 2
- A Feasibility Study Of NAB-Paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine CarcinomasStatus unknownNCT02215447Phase 2
- A Prospective, Multicenter, Open-label 12 Week Neoadjuvant Phase II Trial Optimizing Taxane Therapy in Elderly Patients With Low ResponseCompletedNCT02214381Phase 3
- Dose Escalation of Neoadjuvant Proton Beam Radiotherapy With Concurrent Chemotherapy in Locally Advanced Esophageal CancerActive, not recruitingNCT02213497Phase 1
- Molecular Phenotype Changes and Personalized Treatment for CRPCStatus unknownNCT02208583Not applicable
- A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic CancerActive, not recruitingNCT02207465Phase 1
- Paclitaxel in Combination With Carboplatin Versus Paclitaxel Plus Epirubicin in Metastatic Breast CancerStatus unknownNCT02207361Phase 4
- LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell HistiocytosisActive, not recruitingNCT02205762Phase 2/3
- A Study Evaluating RO5479599 in Combination With Carboplatin and Paclitaxel in Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) of Squamous HistologyTerminatedNCT02204345Phase 1/2
- Phase II-b Randomized Clinical Trial of Cabazitaxel in Metastatic Colorectal Cancer Resistant to Standard TreatmentTerminatedNCT02204332Phase 2
- Addition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast CancerCompletedNCT02199418Phase 2
- Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade GliomaCompletedNCT02197637Phase 2
- Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)Active, not recruitingNCT02194738Not applicable
- Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular CarcinomaCompletedNCT02191878Phase 1/2
- Phase II Clinical Study of Intermittent High Dose of Icotinib in Combination With Docetaxel to Treat Lung CancerStatus unknownNCT02191059Phase 2
- Fractionated Stereotactic Radiotherapy (FSRT) in Treatment of Brain MetastasesTerminatedNCT02187822Phase 1
- Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Metastatic Triple-negative Breast CancerTerminatedNCT02183805Phase 2
- LDE225 + Docetaxel/Prednisone for Adv/Met Castrate Resistant Prostate Cancer w/ Disease Progression After DocetaxelWithdrawnNCT02182622Phase 1
- Dose Escalation Study of BIBF 1120 in Patients With Advanced Gynaecological MalignanciesCompletedNCT02182245Phase 1
- A Dose Escalation Study of BIBF 1120 Together With Paclitaxel and Carboplatin in Patients With Advanced Stage Non-small-cell Lung CancerCompletedNCT02182232Phase 1
- Docetaxel Plus Bevacizumab for Elderly Patients With Stage IV NSCLCTerminatedNCT02179567Phase 2
- Study Assessing the Effects of Chemotherapy in Advanced Esophagogastric AdenocarcinomaStatus unknownNCT02177552Phase 2
- Colchicine for Symptom and Inflammation in Knee OsteoarthritisCompletedNCT02176460Phase 2/3
- Maintenance Low Dose Oral Navelbine In Patients With Non Small Cell Lung Cancer - MA.NI.LA TrialCompletedNCT02176369Phase 2
- Safety and Efficacy Study of Eribulin in Combination With Bevacizumab for Second-line Treatment HER2- MBC PatientsStatus unknownNCT02175446Phase 2
- Biological Effect of Nab-paclitaxel Combined to Gemcitabine in Metastatic Pancreatic CancerCompletedNCT02174887Phase 1
- Hypofractionated Proton Beam Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Stage II-III Non-Small Cell Lung CancerCompletedNCT02172846Phase 1
- Dose Escalation Trial of BIBW 2992 Administration in Combination With Docetaxel in Patients With Advanced Solid TumorsCompletedNCT02171741Phase 1
- BIBW 2992 After Administration of Docetaxel in Patients With Advanced Solid TumorsCompletedNCT02171676Phase 1
- A Study of Cabazitaxel for Patients With Breast or Lung Cancer and Recurrent or Progressive Brain Metastases - Cabazitaxel for Brain Metastases (CaBaMet)TerminatedNCT02166658Phase 2
- Fenretinide Lym-X-Sorb + Ketoconazole + Vincristine for Recurrent or Resistant NeuroblastomaTerminatedNCT02163356Phase 1
- Study on Neoadjuvant Chemotherapy for Advanced Gastric CancerStatus unknownNCT02163291Phase 2
- Colchicine in Vascular Inflammation Assessed With PET ImagingCompletedNCT02162303Phase 2
- Lower Dose Decitabine (DAC)-Primed TC (Carboplatin-Paclitaxel) Regimen in Ovary CancerStatus unknownNCT02159820Phase 2/3
- BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic CancerCompletedNCT02155088Phase 1
- VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid TumorsCompletedNCT02146222Phase 1
- Maintenance Oral Vinorelbine or Observation After Vinorelbine-Docetaxel First Line Chemotherapy in Advanced Breast CaStatus unknownNCT02144194Phase 2
- Weekly and Every 3 Week Administration of Paclitaxel Liposome Injection in Metastatic Breast CancerStatus unknownNCT02142790Phase 4
- Weekly Paclitaxel Liposome Injection Plus Cisplatin in Preoperative Treatment of Breast CancerStatus unknownNCT02142010Not applicable
- Vinorelbine in MesotheliomaCompletedNCT02139904Phase 2
- Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous PaclitaxelTerminatedNCT02138812Phase 1
- Enzalutamide in Combination With Gemcitabine and Nab-Paclitaxel for the Treatment of Advanced Pancreatic CancerCompletedNCT02138383Phase 1
- Bioavailability Study of SPARC1210 and Reference1210 in Subjects With Metastatic Breast CancerTerminatedNCT02136927Phase 1
- Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Advanced Pancreatic CancerStatus unknownNCT02135822Phase 2
- Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNAActive, not recruitingNCT02135042Phase 2/3
- Oshadi D and Oshadi R in Combination With Docetaxel, as 2nd Line Therapy for Metastatic Non Small Cell Lung CancerStatus unknownNCT02134990Phase 2
- Dose-escalating, Safety, Tolerability and PK Study of TAS-119 in Combination With Paclitaxel in Patients With Advanced Solid TumorsTerminatedNCT02134067Phase 1
- Safety Study of TPI-287 to Treat CBS and PSPCompletedNCT02133846Phase 1
- Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell CarcinomaCompletedNCT02133612Phase 2
- Pancreatic Resectability in Cancers With Known Limited Extension (PRICKLE)TerminatedNCT02124369Phase 2
- Nab-paclitaxel Plus S-1 in Patients With Advanced Pancreatic CancerStatus unknownNCT02124317Phase 2
- Colchicine in Coronary Artery Bypass Graft (CABG)CompletedNCT02122484Phase 4
- Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube CancerCompletedNCT02121990Phase 1
- Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) in Treatment Failure Solid TumorsWithdrawnNCT02120118Phase 2
- Phase I BKM120/Abraxane in Solid Tumors, Expansion Phase Recurrent Endometrial or Ovarian CancerWithdrawnNCT02117817Phase 1
- 4 x Epirubicin, Cyclophosphamide, Followed by 4 x Docetaxel Versus 6 x CMF / 6 x CEFCompletedNCT02115204Phase 3
- A Prospective Study of Cabazitaxel in Patients With Non Seminomatous Germ-cell TumorsCompletedNCT02115165Phase 2
- Safety Study of SBRT and Docetaxel for Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Head and NeckTerminatedNCT02110992Phase 1
- Phase I/II Study to Evaluate Nab-paclitaxel in Substitution of CPT11 or Oxaliplatin in FOLFIRINOX Schedule as First Line Treatment in Metastatic Pancreatic CancerCompletedNCT02109341Phase 1/2